LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Kano Therapeutics

Kano Therapeutics harnesses the power of DNA nanotechnology to design and engineer functional gene vectors to expand the reach of genome-editing-based therapies. Instead of innovating around the gene-editing and delivery tools (the messenger), we start by innovating around the DNA vector that carries the genetic information (the message).

  • Floris Engelhardt CEO